Baumberger, P. (2007). Prävention von Rauschtrinken in Jugendgruppen. SuchtMagazin, 33(4; 08/2007), 24–26.
Keywords: prevention; AOD use, abuse, and dependence; chemical addiction; alcohol; adolescent; young adult; journal article
|
Sonderegger Sowe, M., & Eicke, M. (2007). Teamplay – Fortbildung für Fussballtrainer : Caritas und Fussballverbände schlagen gemeinsam neue Wege ein. SuchtMagazin, 33(5; 10/2007), 26–28.
Keywords: sports; soccer; journal article
|
Gander, T. (2007). EURO08 als Antrieb für die lokale sozialpädagogische Fanarbeit? SuchtMagazin, 33(5; 10/2007), 23–25.
Keywords: sports; soccer; journal article
|
Häfeli, J. (2007). Prävention im Profifussballbereich : ein Feld mit Entwicklungspotential. SuchtMagazin, 33(5; 10/2007), 17–22.
Keywords: sports; soccer; journal article
|
Hafen, M. (2007). Theorie, Praxis und Professionalisierung in der (Sucht-)Prävention. SuchtMagazin, 33(6; 12/2007), 16–19.
Keywords: addiction care; prevention; history; journal article
|
Wernli, T. (2007). SuchtMagazin, DrogenMagazin, die Kette. SuchtMagazin, 33(6; 12/2007), 10–15.
Keywords: addiction care; prevention; history; journal article
|
Jost, K. (2007). Nur wer sich ändert, bleibt sich treu : Blitzlichter auf viele grosse und kleine Veränderungen in 40 Jahren Suchtarbeit. SuchtMagazin, 33(6; 12/2007), 6–9.
Keywords: addiction care; prevention; history; journal article
|
Meyer, M. (2007). Menschenbilder in der Suchtprävention. SuchtMagazin, 33(6; 12/2007), 20–24.
Keywords: addiction care; prevention; history; journal article
|
Huber, M., Weber, R., Oppliger, R., Vernazza, P., Schmid, P., Schönbucher, P., et al. (2005). Interferon-alpha2a plus ribavirin 1000/1200 mg versus interferon-alpha2a plus ribavirin 600 mg for treatment of chronic hepatitis C among patients in opiate substitution programs : an open-label randomized multicenter trial : Korrekturexemplar. Infection, 33(1), 93–97.
Abstract: Background: Many intravenous opiate users are infected with hepatitis C virus (HCV) but few are treated. Although this complies with various guidelines, virtually no published evidence supports such a recommendation. Patients and Methods: In a multicenter study, HCV-infected patients in opiate maintenance treatment programs received interferon plus high- or low-dose ribavirin (1000/1200 mg or 600 mg). HIV-coinfected patients were not included. Endpoints were feasibility, efficacy, side effects, and reasons for dropout. Results: Of the 420 patients who tested positive for HCV, 27 (6%) were enrolled; 393 (94%) either failed to meet the inclusion criteria or refused treatment. Virologic end-of-treatment response was achieved in 12/27 patients, and sustained response in 13/27 (48%). Response depended on viral genotype, not ribavirin dose. The two doses of ribavirin did not differ in their side effects. Conclusion: In a small fraction of HCV-infected intravenous drug users in an opiate maintenance treatment program, antiviral therapy was feasible, safe and effective. The success rate was comparable to that achieved in controlled studies that excluded drug users.
Keywords: health promotion; viral hepatitis; hepatitis C
|
Siegrist Mastai, Y., & Kessler, O. (2006). Gesundheit im Betrieb ist Führungsaufgabe. SuchtMagazin, 32(5; 10/2006), 26–27.
Keywords: labor and work; health promotion; workplace context; Hochschule für Soziale Arbeit Luzern (body); Hochschule für Wirtschaft Luzern (body); Switzerland; Lucerne
|